AstraZeneca's total assets for Q4 2024 were $104.03B, a decrease of -0.85% from the previous quarter. AZN total liabilities were $63.16B for the fiscal quarter, a -1.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.